NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Subjects United States Remove constraint Subjects: United States

Search Results

801. Medical product communications that are consistent with the FDA-required labeling: questions and answers

802. Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff

803. Logical observation identifiers names and codes for in vitro diagnostic tests: guidance for industry and Food and Drug Administration staff

804. S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers

805. Assessing user fees under the biosimilar user fee amendments of 2017

807. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components

809. Use of electronic health record data in clinical investigations